GT Medical Technologies: Pioneering a New Paradigm for Brain Tumor Radiotherapy

GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.

GammaTile Therapy

The 24 best medical device innovations of 2022

GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.

ABC 7 WKBW Buffalo

Glioblastoma Awareness Day

Today is Glioblastoma Awareness Day

Posted at 5:54 PM, Jul 20, 2022 and last updated 5:54 PM, Jul 20, 2022
Today is Glioblastoma Awareness Day, a day to help those affected by this devastating disease and remember lives lost to Glioblastoma (GMB), lives like Senator John McCain, and Mike Traphagen.

David Brachman, M.D.

For his invention of GammaTile® Therapy used to treat operable brain tumors, David Brachman, M.D. is the 2022 winner of the Mensa Foundation’s Copper Black Award for Creative Achievement.

GESTALT Clinical Trial

GT Medical Technologies Earns ISO and MDSAP Certifications

GT Medical Technologies announced today that it has earned the International Organization for Standardization (ISO) 13485:2016 certification from GMED. The certification demonstrates the company’s compliance with medical device quality management system requirements under the Medical Device Single Audit Program (MDSAP).